Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-22-004779

10% owner bought 12,551 shares at an average $4.19 ($52,642)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cambrian BioPharma Inc 10% owner 2022-02-14 Purchase +10,000 $4.18 $41,800 5,185,786 D: show line 1 in the form
Cambrian BioPharma Inc 10% owner 2022-02-16 Purchase +2,551 $4.25 $10,842 5,188,337 D: show line 2 in the form
Open-market purchases · 12,551 sh · avg $4.19 · $52,642
Loading xslF345X03/doc1.xml…